Clinical Trials Browser

Phase 4 × OTHER × Pemetrexed × Clear all

NCT05689671 2026-03-10

ANTELOPE

Phase 4 Active not recruiting

Non-Small Cell Lung Cancer Metastatic

NCT03656549 2024-12-17

IMPROVE-I

Phase 4 Completed

Other solid neoplasmThoracic

Carcinoma, Non-Small-Cell Lung, Mesothelioma

NCT06357598 2024-04-10

PILOT

Phase 4 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT03655821 2022-05-13

IMPROVE-II

Phase 4 Terminated

Other solid neoplasmThoracic

Carcinoma, Non-Small-Cell Lung, Mesothelioma

NCT03655834 2022-05-10

IMPROVE-III

Phase 4 Completed

Other solid neoplasmThoracic

Carcinoma, Non-Small-Cell Lung, Mesothelioma

NCT03607149 2021-05-24

PKAPIR

Phase 4 Completed

Carcinoma, Non-Small-Cell Lung

NCT02031601 2016-03-29

TCL-1

Phase 4 Unknown

Carcinoma, Non-Small-Cell Lung

NCT02399566 2015-03-26

Clinical Trial of Erlotinib and Pemetrexed for Maintenance Treatment in Lung Adenocarcinoma

Phase 4 Unknown

Adenocarcinoma of Lung